New COVID-19 drug candidate passes first safety check in healthy volunteers
Disease control
Completed
This early-stage trial tested the safety and tolerability of a new drug called PA-001 in 47 healthy and elderly volunteers. Participants received either PA-001 or a placebo through an IV. The main goal was to see if the drug causes any side effects and to understand how the body …
Phase: PHASE1 • Sponsor: PeptiDream Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC